Paradigm shift redefining molecular, metabolic and structural events in Alzheimer’s disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration

Cavaleri, F. (2015). Paradigm shift redefining molecular, metabolic and structural events in Alzheimer’s disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration. <em>Medical Hypotheses</em>. https://doi.org/10.1016/j.mehy.2015.01.044

Cavaleri F. Paradigm shift redefining molecular, metabolic and structural events in Alzheimer’s disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration. Medical Hypotheses. 2015. doi:10.1016/j.mehy.2015.01.044.

@article{franco2015Paradi, title = {Paradigm shift redefining molecular, metabolic and structural events in Alzheimer’s disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration}, author = {Franco Cavaleri}, journal = {Medical Hypotheses}, year = {2015}, doi = {10.1016/j.mehy.2015.01.044}, }